NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

FemtoDx

Business Name:
FemtoDx
Business Genre:
Business Description:

Company focus is home-based monitoring of cardiovascular diseases with a panel of clinically validated biomarkers [1]. They aim to improve the quality of point-of-care tests to meet needs of medical professionals. They collaborate with universities and hospitals in LA and partner with leading product development and manufacturing companies [1].

City:
Beverly Hills
State:
CA
Country:
USA
Data/Evidence of Effectiveness:
N/A
Complimentary Products Needed to Perform Test:
Assuming all necessary supplies are provided in the kit since the company stresses on the ease of use at home and not requiring a lab or a technician [2].
Setting of Care:
At home and with healthcare providers [2].
Current Status / Clinical Development Stage / Expected Milestones:
Company announced plan to develop a rapid in-home test in April [4]. Seems like the product needs to be developed, sensitivity tests be run and EUA approval should be acquired before it’s available.
Funding & Ownership :
Private (undisclosed) venture backed [3].
Business Model:
They are a medical device company specializing in Semiconductor Physics, Biochemistry, Microfluidics, Si Devices, and Clinical Chemistry [3].
IP:
N/A
History & Origins :
Company was founded in 2014 [3]. Originated from years of academic research. FemtoDx provides the resources to solve some of the most challenging problems in healthcare. They perform product design, development, and manufacturing in partnership with the country’s leading companies [2]. It appears that their specialty is creating devices to detect heart failure and stroke before they occur [1].
Date EUA Issued:
N/A
Sources:
1. https://femtodx.com/ 2. https://femtodx.com/news/2020/3/31/femtodx-launches-rapid-at-home-test-development-for-covid-19 3. https://www.linkedin.com/company/femtodx/about/ 4. https://www.mddionline.com/fda-grants-eua-labcorps-home-covid-19-test
Organization:
“Raj Mohanty, PhD- CEO, Founder & Board Member Shyam Erramilli, PhD- Founder, SAB Chairman Sanjiv Taneja- Chief Operating Officer David Weaver, PhD- Chief Scientific Officer Stan Lapidus- Senior Advisor Carla Sivak- Regulatory & Quality Affairs Hiroo Awano- Corporate Development Robert Dinello, PhD- Director of Assay Development Patrick Anquetil, PhD- Board Member Rahul Baldota- Board Member Steve Steinhubl, MD- Advisor Sudhakar Pamarti, PhD- Advisor [1].”
No. Tests Per Day:
serology strip >2000/ day
Time to Result:
Under 5 minutes [2].
Test Sample Type:
N/A
Technology Overview:
Specifics N/A. The test seems to still be in development [2,4]. Patients can perform the test themselves at home without needing a lab or technician [2]. More importantly, time from sample to result is less than five minutes [2].The test will be performed by the patients at home, or by health care providers at other points of care, with an easy-to-use device, which is connected to the cloud and patients’ electronic medical records for immediate intervention when needed [2]. FemtoDx’s test uses the same indicators that are analyzed in a traditional reference lab [2]
Testing Type:
N/A
Test Category:
Other
Test Name:
COVID-19 Test [1,2]
Clinical Application & Need:
Rapid diagnostic test to allow patients and providers to reliably determine whether they have a COVID-19 infection and help reduce the spread of the virus [2].
Age of Company:
2014 [3]

Send Message to listing owner

Leave A Reply